Skip to content

Clinical trials

Recruiting Hemoglobinuria, Paroxysmal trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemoglobinuria, Paroxysmal Status: Recruiting Country / region: China Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20201
20244
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Wuhan Createrna Science and Technology Co., Ltd3
Haisco Pharmaceutical Group Co., Ltd.2
Institute of Hematology & Blood Diseases Hospital, China1
Jiangsu Hansoh Pharmaceutical Co., Ltd.1
Novartis Pharmaceuticals1
S-INFINITY Pharmaceuticals Co., Ltd1
Shanghai Lanyi Therapeutics Co., Ltd.1
Shenzhen Kangzhe Biotechnology Co., Ltd.1
Zhuhai United Laboratories Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemoglobinuria, Paroxysmal12
Anemia, Aplastic1
Anemia, Hemolytic, Autoimmune1
Hemophilia A1
Hemophilia B1
Hemostatic Disorders1
Leukemia1
Leukemia, Large Granular Lymphocytic1
Leukemia, Myeloid, Acute1
Lymphoma1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.